Learn more

MAGIS FARMACEUTICI

Overview
  • Total Patents
    362
About

MAGIS FARMACEUTICI has a total of 362 patent applications. Its first patent ever was published in 1979. It filed its patents most often in Italy, EPO (European Patent Office) and United States. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are COREY ELIAS J, TRIUS THERAPEUTICS and ENDO PRODUCTS INC.

Patent filings in countries

World map showing MAGIS FARMACEUTICIs patent filings in countries

Patent filings per year

Chart showing MAGIS FARMACEUTICIs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Puricelli Laura 208
#2 Moroni Adolfo 133
#3 Schiena Michele Di 9
#4 Di Schiena Michele 7
#5 Moroni Enzo 4
#6 Stradi Riccardo 3
#7 Puricelli L 3
#8 Adolfo Moroni 2
#9 Maroni Adolfo 2
#10 Accardi Italo 1

Latest patents

Publication Filing date Title
EP0557936A1 Amidic derivatives of (R)-glycerophosphoryl-(S)-serine or of its diacyl derivative, process for their preparation and relative pharmaceutical compositions for the improvement of the learning processes
EP0513703A2 Carbamate esters of eseroline having anticholinesterase activity, a process for their preparation and relative pharmaceutical compositions containing them as the active principle
US5215973A Optically active and racemic hydrated diacetylesters of α-glycero-phosphoryl-choline
EP0502357A1 Optically active and racemic hydrated diacetylesters of alpha-glycero-phosphoryl-choline
EP0486100A1 Process for preparing alpha-glycerophosphorylcholine
ITMI912027D0 New eseroline derivs. having anti-cholinesterase activity - used for treating Alzheimer's disease, pain myasthenia gravis, glaucoma, memory dysfunction and neuromuscular disorders
ITMI911758D0 Derivatives of physovenine useful for the treatment of diseases associated with cholinergic disorders, process for their preparation and pharmaceutical compositions which contain them
ITMI911713D0 Derivatives of eseridine useful for the treatment of diseases associated with cholinergic disorders, process for their preparation and pharmaceutical compositions which contain them
ITMI911653D0 Eseridine derivatives with anticholinesterase activity, process for their preparation and pharmaceutical compositions which contain them
ITMI911444D0 Derivatives of eseroline with anticholinesterase activity, process for their preparation and pharmaceutical compositions which contain them
ITMI911387A1 Process for the preparation of L-&alpha-glyceryl phosphoryl ethanolamine and L-&alpha-(diacetyl)-glyceryl phosphoryl ethanolamine, in the anhydrous, monohydrated, dihydrated and trihydrated forms
ITMI911388A1 Process for the preparation of L-&alpha-glyceryl phosphoryl-L-serine and L-&alpha-(diacetyl)-glyceryl phosphoryl-L-serine, in the anhydrous, monohydrated, dihydrated and trihydrated forms
ITMI911380A1 Compounds with anti-inflammatory activity and pharmaceutical formulations which contain them
ITMI911369A1 Process for the preparation of L-&alpha-glyceryl phosphoryl choline
ITMI911335A1 Compounds with anticholinesterase activity, process for their preparation and pharmaceutical compositions which contain them
ITMI911298A1 Compounds with anticholinesterase activity, process for their preparation and pharmaceutical compositions which contain them
ITMI911300A1 Process for the preparation of L-&alpha- glycerylphosphoryl serine and its corresponding diacetyl derivative
ITMI911069A1 Process for the preparation of L-1,2 diacetylglycerophosphorylcholine monohydrate
ITMI911070A1 Process for the preparation of L-alpha glycerophosphorylcholine
ITMI910590A1 Optically active hydrated diacetyl esters and racemic mixtures of &alpha-glycerophosphorylcholine.